EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists

Hiroyuki Murota iD, Mai Matsumoto, Kazuhiko Arima iD, Takuo Yoshida iD, Hiroyuki Fujita iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Hiroyuki Murota und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagasaki University, Nagasaki, Nagasaki, Japan. Hauptthemen laut MEDLINE: Prurigo, Practice Patterns, Physicians', Dermatologists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prurigo nodularis (PN) is a chronic inflammatory skin disease associated with intense pruritic nodules. The unclear patho‐etiological mechanisms of PN cause difficulty in disease management; and there is a paucity of information on the current diagnosis and treatment options for PN in Japan. To describe the current management from a dermatologists' perspective we conducted a web‐based survey (UMIN Clinical Trial Registry UMIN000047643) in 2022 among dermatologists from a Japanese commercially available physician panel, who had seen at least one patient with PN within the last 3 months. The survey included 117 dermatologists. The dermatologists diagnosed PN mainly by confirming clinical signs and patient interviews, while to assess the severity of PN, the number of pruritic nodules and the degree of itching were primarily utilized. Topical corticosteroids and antihistamines were the most used drugs, as recommended in the current guidelines on the diagnosis and treatment of prurigo. Dermatologists' treatment satisfaction decreased with increasing assumed severity of PN; almost 65% dermatologists were not satisfied with the treatment of severe PN. These results suggest the need of more effective medications and diagnostic tools for better management of PN in Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrurigoPractice Patterns, Physicians'DermatologistsHumansJapanCross-Sectional StudiesHistamine AntagonistsSeverity of Illness IndexAdrenal Cortex HormonesPractice Guidelines as TopicFemaleMaleSurveys and QuestionnairesPruritusDermatologyMiddle AgedAdultInternet

Stichwörter der Autor:innen

Japandermatologydisease severityprurigopruritus

Substanzen

Histamine AntagonistsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Dermatology, Nagasaki University, Nagasaki, Nagasaki, Japan.
  • Sanofi, Tokyo Opera City Tower, Tokyo, Japan.

ORCID-Profile: Hiroyuki Murota, Kazuhiko Arima, Takuo Yoshida, Hiroyuki Fujita

Zitieren

APA

Murota, H., Matsumoto, M., Arima, K., Yoshida, T., & Fujita, H. (2025). Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17400

Vancouver

Murota H, Matsumoto M, Arima K, Yoshida T, Fujita H. Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17400

BibTeX
@article{Murota2025,
  author = {Murota, Hiroyuki and Matsumoto, Mai and Arima, Kazuhiko and Yoshida, Takuo and Fujita, Hiroyuki},
  title = {Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17400}
}
Kostenlos starten →